| [1] |
Paixão TM, Teixeira LR, Andrade CAF, et al. Systematic Review and Meta-Analysis of Metabolic Syndrome and Its Components in Latino Immigrants to the USA [J]. Int J Environ Res Public Health, 2023, 20(2): 1307.
|
| [2] |
Huang Y, Zhang L, Wang Z, et al. The prevalence and characteristics of metabolic syndrome according to different definitions in China: a nationwide cross-sectional study, 2012-2015 [J]. BMC Public Health, 2022, 22(1): 1869.
|
| [3] |
Kong P, Cui ZY, Huang XF, et al. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention [J]. Signal Transduct Target Ther, 2022, 7(1): 131.
|
| [4] |
Xu JJ, Song Y, Jiang P, et al. Eff ects of metabolic syndrome on onset age and long-term outcomes in patients with acute coronary syndrome [J]. World J Emerg Med, 2021, 12(1): 36-41.
|
| [5] |
Opio J, Wynne K, Attia J, et al. Overweight or obesity increases the risk of cardiovascular disease among older Australian adults, even in the absence of cardiometabolic risk factors: a Bayesian survival analysis from the Hunter Community Study [J]. Int J Obes (Lond), 2023, 47(2): 117-125.
|
| [6] |
Iso H, Cui R, Takamoto I, et al. Risk Classification for Metabolic Syndrome and the Incidence of Cardiovascular Disease in Japan With Low Prevalence of Obesity: A Pooled Analysis of 10 Prospective Cohort Studies [J]. J Am Heart Assoc, 2021, 10(23): e020760.
|
| [7] |
Alshammary AF, Alharbi KK, Alshehri NJ, et al. Metabolic Syndrome and Coronary Artery Disease Risk: A Meta-Analysis of Observational Studies [J]. Int J Environ Res Public Health, 2021, 18(4): 1773.
|
| [8] |
Li X, Li X, Lin H, et al. Metabolic syndrome and stroke: A meta-analysis of prospective cohort studies [J]. J Clin Neurosci, 2017, 40: 34-38.
|
| [9] |
Zhang F, Liu L, Zhang C, et al. Association of Metabolic Syndrome and Its Components With Risk of Stroke Recurrence and Mortality: A Meta-analysis [J]. Neurology, 2021, 97(7): e695-e705.
|
| [10] |
Cho JH, Rhee EJ, Park SE, et al. The Risk of Myocardial Infarction and Ischemic Stroke According to Waist Circumference in 21 749 261 Korean Adults: A Nationwide Population-Based Study [J]. Diabetes Metab J, 2019, 43(2): 206-221.
|
| [11] |
Liu X, Zhang D, Liu Y, et al. A J-shaped relation of BMI and stroke: Systematic review and dose-response meta-analysis of 4.43 million participants [J]. Nutr Metab Cardiovasc Dis, 2018, 28(11): 1092-1099.
|
| [12] |
Chen W, Pan Y, Jing J, et al. Recurrent Stroke in Minor Ischemic Stroke or Transient Ischemic Attack With Metabolic Syndrome and/or Diabetes Mellitus [J]. J Am Heart Assoc, 2017, 6(6): e005446.
|
| [13] |
Huang Q, Yin L, Liu Z, et al. Association of novel lipid indicators with the risk of stroke among participants in Central China: a population-based prospective study [J]. Front Endocrinol (Lausanne). 2023.14:1266552.
|
| [14] |
Liu Z, Huang Q, Deng B, et al. Elevated Chinese visceral adiposity index increases the risk of stroke in Chinese patients with metabolic syndrome [J]. Front Endocrinol (Lausanne), 2023, 14: 1218905.
|
| [15]] |
Bauersachs R, Zeymer U, Brière JB, et al. Burden of Coronary Artery Disease and Peripheral Artery Disease: A Literature Review [J]. Cardiovasc Ther, 2019, 2019: 8295054.
|
| [16] |
Soriano-Moreno DR, Fernandez-Morales J, Medina-Ramirez SA, et al. Metabolic Syndrome and Risk of Peripheral Arterial Disease: A Systematic Review and Meta-Analysis [J]. Cardiol Rev, 2022.
|
| [17] |
Gami A, Witt B, Howard D, et al. Metabolic Syndrome and Risk of Incident Cardiovascular Events and Death: A Systematic Review and Meta-Analysis of Longitudinal Studies [J]. J Am Coll Cardiol, 2007, 49(4): 403-414.
|
| [18] |
Maksimovic M, Vlajinac H, Radak D, et al. Relationship between peripheral arterial disease and metabolic syndrome [J]. Angiology, 2009, 60(5): 546-553.
|
| [19] |
Gao L, Zhao W, Liu Q, et al. Association Between Metabolic Syndrome and Peripheral Arterial Disease in Elderly Patients with Type 2 Diabetes [J]. Diabetes Metab Syndr Obes, 2021, 14: 4783-4789.
|
| [20] |
Chen Q, Zhu H, Shen F, et al. Sex-influenced association of metabolic syndrome with lower extremity arterial disease in type 2 diabetes [J]. J Diabetes Complications, 2020, 34(5): 107537.
|
| [21] |
Masenga SK, Kabwe LS, Chakulya M, et al. Mechanisms of Oxidative Stress in Metabolic Syndrome [J]. Int J Mol Sci, 2023, 24(9): 7898.
|
| [22] |
Aboonabi A, Meyer RR, Singh I. The association between metabolic syndrome components and the development of atherosclerosis [J]. J Hum Hypertens, 2019, 33(12): 844-855.
|
| [23] |
Vergès B. Pathophysiology of diabetic dyslipidaemia: where are we? [J]. Diabetologia, 2015, 58(5): 886-899.
|
| [24] |
Förstermann U, Xia N, Li H. Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis [J]. Circ Res, 2017, 120(4): 713-735.
|
| [25] |
Mitra R, O'Neil GL, Harding IC, et al. Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target [J]. Curr Atheroscler Rep, 2017, 19(12): 63.
|
| [26] |
Förstermann U, Xia N, Li H. Roles of Vascular Oxidative Stress and Nitric Oxide in the Pathogenesis of Atherosclerosis [J]. Circ Res, 2017, 120(4): 713-735.
|
| [27] |
Torres S, Fabersani E, Marquez A, et al. Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics [J]. Eur J Nutr, 2019, 58(1): 27-43.
|
| [28] |
Saltiel AR, Olefsky JM. Inflammatory mechanisms linking obesity and metabolic disease [J]. J Clin Invest, 2017, 127(1): 1-4.
|
| [29] |
Wu J, He S, Song Z, et al. Macrophage polarization states in atherosclerosis [J]. Front Immunol, 2023, 14: 1185587.
|
| [30] |
Zhang S, Gang X, Yang S, et al. The Alterations in and the Role of the Th17/Treg Balance in Metabolic Diseases [J]. Front Immunol, 2021, 12: 678355.
|
| [31] |
Kang SG, Piniecki RJ, Hogenesch H, et al. Identification of a Chemokine Network That Recruits FoxP3+ Regulatory T Cells Into Chronically Inflamed Intestine [J]. Gastroenterology, 2007, 132(3): 966-981.
|
| [32]] |
van Diepen JA, Berbée JF, Havekes LM, et al. Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis [J]. Atherosclerosis, 2013, 228(2): 306-315.
|
| [33] |
O'Neill BJ. Effect of low-carbohydrate diets on cardiometabolic risk, insulin resistance, and metabolic syndrome [J]. Curr Opin Endocrinol Diabetes Obes, 2020, 27(5): 301-307.
|
| [34] |
Stanek A, Brożyna-Tkaczyk K, Zolghadri S, et al. The Role of Intermittent Energy Restriction Diet on Metabolic Profile and Weight Loss among Obese Adults [J]. Nutrients, 2022, 14(7): 1509.
|
| [35] |
Xu R, Cao Y, Wang PY, et al. Intermittent energy restriction vs. continuous energy restriction on cardiometabolic risk factors in patients with metabolic syndrome: a meta-analysis and systematic review [J]. Front Nutr, 2023, 10: 1090792.
|
| [36] |
Alkhulaifi F, Darkoh C. Meal Timing, Meal Frequency and Metabolic Syndrome [J]. Nutrients, 2022, 14(9): 1719.
|
| [37] |
Franczyk B, Gluba-Brzózka A, Ciałkowska-Rysz A, et al. The Impact of Aerobic Exercise on HDL Quantity and Quality: A Narrative Review [J]. Int J Mol Sci, 2023, 24(5): 4653.
|
| [38] |
Battista F, Ermolao A, van Baak MA, et al. Effect of exercise on cardiometabolic health of adults with overweight or obesity: Focus on blood pressure, insulin resistance, and intrahepatic fat-A systematic review and meta-analysis [J]. Obes Rev, 2021, 22(Suppl 4): e13269.
|
| [39] |
Bray GA, Greenway FL. Pharmacological treatment of the overweight patient [J]. Pharmacol Rev, 2007, 59(2): 151-184.
|
| [40] |
Chao AM, Tronieri JS, Amaro A, et al. Semaglutide for the treatment of obesity [J]. Trends Cardiovasc Med, 2023, 33(3): 159-166.
|
| [41] |
Merćep I, Vujević A, Strikić D, et al. Present and Future of Dyslipidaemia Treatment-A Review [J]. J Clin Med, 2023, 12(18): 5839.
|
| [42] |
Katsimardou A, Imprialos K, Stavropoulos K, et al. Hypertension in Metabolic Syndrome: Novel Insights [J]. Curr Hypertens Rev, 2020, 16(1): 12-18.
|
| [43] |
Castrejón-Téllez V, Villegas-Romero M, Rubio-Ruiz ME, et al. Effect of a Resveratrol/Quercetin Mixture on the Reversion of Hypertension Induced by a Short-Term Exposure to High Sucrose Levels Near Weaning and a Long-Term Exposure That Leads to Metabolic Syndrome in Rats [J]. Int J Mol Sci, 2020, 21(6): 2231.
|
| [44] |
Villegas Vílchez LF, Ascencios JH, Dooley TP. GlucoMedix®, an extract of Stevia rebaudiana and Uncaria tomentosa, reduces hyperglycemia, hyperlipidemia, and hypertension in rat models without toxicity: a treatment for metabolic syndrome [J]. BMC Complement Med Ther, 2022, 22(1): 62.
|
| [45] |
Chandrakumar H, Khatun N, Gupta T, et al. The Effects of Bariatric Surgery on Cardiovascular Outcomes and Cardiovascular Mortality: A Systematic Review and Meta-Analysis [J]. Cureus, 2023, 15(2): e34723.
|
| [46] |
Ardissino M, Watson F, Amin R, et al. Atherosclerotic disease burden after bariatric surgery in patients with obesity and type 2 diabetes [J]. J Diabetes, 2021, 13(8): 640-647.
|
| [47] |
Yang W, Zhan M, Li Z, et al. Major Adverse Cardiovascular Events Among Obese Patients with Diabetes After Metabolic and Bariatric Surgery: a Meta-analysis of Matched Cohort and Prospective Controlled Studies with 122,361 Participates [J]. Obes Surg, 2023, 33(7): 2098-2107.
|
| [48] |
Arias A, Rodríguez-álvarez C, González-Dávila E, Acosta-Torrecilla A, Novo-Muñoz MM, Rodríguez-Novo N. Arterial Hypertension in Morbid Obesity after Bariatric Surgery: Five Years of Follow-Up, a Before-And-After Study [J]. Int J Environ Res Public Health, 2022, 19(3): 1575.
|
| [49] |
Valera RJ, Sarmiento-Cobos M, Montorfano L, et al. The impact of bariatric surgery on hospitalization due to peripheral artery disease and critical limb ischemia: a nationwide analysis [J]. Surg Obes Relat Dis. 2023, 19(10):1162-1168.
|
| [50] |
Moussa O, Ardissino M, Muttoni S, et al. Long-term incidence and outcomes of obesity-related peripheral vascular disease after bariatric surgery [J]. Langenbecks Arch Surg, 2021, 406(4): 1029-1036.
|
| [51] |
Kirwan JP, Courcoulas AP, Cummings DE, et al. Diabetes Remission in the Alliance of Randomized Trials of Medicine Versus Metabolic Surgery in Type 2 Diabetes (ARMMS-T2D) [J]. Diabetes Care, 2022, 45(7): 1574-1583.
|
| [52] |
杨华, 张鹏, 董志勇, 等. 中国肥胖代谢外科手术方式推荐立场声明 [J/CD]. 中华肥胖与代谢病电子杂志, 2021, 7(1): 8-12.
|